Vancomycin-associated nephrotoxicity: A critical appraisal of risk with high-dose therapy

International Journal of Antimicrobial Agents

Volumn 37, Issue 2, 2011, Pages 95-101

  Wong Beringer, Annie ^a,b   Joo, Julianne ^c   Tse, Edmund ^b   Beringer, Paul ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b HUNTINGTON MEMORIAL HOSPITAL   (United States)

^c OLIVE VIEW UCLA MEDICAL CENTER   (United States)

Author keywords

Acute kidney injury; High dose vancomycin; Nephrotoxicity; Renal biomarkers

Indexed keywords

VANCOMYCIN;

CREATININE CLEARANCE; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG EXPOSURE; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; KIDNEY DYSFUNCTION; MEDICAL DECISION MAKING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NEPHROTOXICITY; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; SIDE EFFECT; TREATMENT DURATION;

EID: 78751569980     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.10.013     Document Type: Short Survey

References (22)

1. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
2. A.W. Chow, and R.M. Azar Glycopeptides and nephrotoxicity Intensive Care Med 20 Suppl. 4 1994 S23 S29
3. M. Rybak, B. Lomaestro, J.C. Rotschafer, R. Moellering Jr., W. Craig, and M. Billeter Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists Am J Health Syst Pharm 66 2009 82 98
4. T. Nakamura, M. Takano, M. Yasuhara, and K. Inui In-vivo clearance study of vancomycin in rats J Pharm Pharmacol 48 1996 1197 1200
5. C. Dieterich, A. Puey, S. Lin, R. Swezey, A. Furimsky, and D. Fairchild Gene expression analysis reveals new possible mechanisms of vancomycin-induced nephrotoxicity and identifies gene markers candidates Toxicol Sci 107 2009 258 269
6. T.G. Cantu, N.A. Yamanaka-Yuen, and P.S. Lietman Serum vancomycin concentrations: reappraisal of their clinical value Clin Infect Dis 18 1994 533 543
7. M.J. Rybak, L.M. Albrecht, S.C. Boike, and P.H. Chandrasekar Nephrotoxicity of vancomycin, alone and with an aminoglycoside J Antimicrob Chemother 25 1990 679 687
8. C.A. Wood, S.J. Kohlhepp, P.W. Kohnen, D.C. Houghton, and D.N. Gilbert Vancomycin enhancement of experimental tobramycin nephrotoxicity Antimicrob Agents Chemother 30 1986 20 24
9. E.D. Hermsen, M. Hanson, J. Sankaranarayanan, J.A. Stoner, M.C. Florescu, and M.E. Rupp Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections Expert Opin Drug Saf 9 2010 9 14
10. L.K. Hidayat, D.I. Hsu, R. Quist, K.A. Shriner, and A. Wong-Beringer High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity Arch Intern Med 166 2006 2138 2144
11. M.N. Jeffres, W. Isakow, J.A. Doherty, S.T. Micek, and M.H. Kollef A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia Clin Ther 29 2007 1107 1115
12. K. Kralovicova, S. Spanik, J. Halko, J. Netriova, M. Studena-Mrazova, and J. Novotny Do vancomycin serum levels predict failures of vancomycin therapy or nephrotoxicity in cancer patients? J Chemother 9 1997 420 426 (Pubitemid 28012794)
13. T.P. Lodise, B. Lomaestro, J. Graves, and G.L. Drusano Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity Antimicrob Agents Chemother 52 2008 1330 1336
14. T.P. Lodise, N. Patel, B.M. Lomaestro, K.A. Rodvold, and G.L. Drusano Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients Clin Infect Dis 49 2009 507 514
15. A.E. Zimmermann, B.G. Katona, and K.I. Plaisance Association of vancomycin serum concentrations with outcomes in patients with Gram-positive bacteremia Pharmacotherapy 15 1995 85 91
16. M. Nguyen, J. Wong, C. Lee, L. Nguyen, R. Quist, and C. Hirokawa Nephrotoxicity associated with high dose vs. standard dose vancomycin therapy 47th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 17-20 September 2007, Chicago, IL 2007 ASM Press Washington, DC Abstract K-1096
17. K. Prabaker, T. Tran, T. Pratummas, M. Goetz, and C. Graber Association of vancomycin trough levels with nephrotoxicity 47th Annual Meeting of Infectious Diseases Society of America 29 October-1 November 2009, Philadelphia, PA 2009 IDSA Arlington, VA Abstract 192
18. A. Mora, K. Dzintars, A. Lat, C.R. Frei, and K. Echevarria Incidence of vancomycin nephrotoxicity in the absence of concomitant nephrotoxins or confounders 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 12-15 September 2009, San Francisco, CA 2009 ASM Press Washington, DC Abstract A1-1294b
19. C. Pounders, T. Allison, and E. Rios Evaluation of vancomycin nephrotoxicity in patients with methicillin-resistant Staphylococcus aureus bacteremia 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 12-15 September 2009, San Francisco, CA 2009 ASM Press Washington, DC Abstract A1-1294a
20. N.Z. Haque, P.O. Kiyan, K. Reyes, C.L. Moore, P. Peyrani, and J.A. Ramirez Nephrotoxicity in Intensive Care Unit patients with hospital-acquired pneumonia: the IMPACT-HAP Project 47th Annual Meeting of Infectious Diseases Society of America 29 October-1 November 2009, Philadelphia, PA 2009 IDSA Arlington, VA Abstract 388
21. R.L. Mehta, J.A. Kellum, S.V. Shah, B.A. Molitoris, C. Ronco, and D.G. Warnock Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury Crit Care 11 2007 R31
22. F.M. Goodsaid, M. Blank, F. Dieterle, P. Harlow, E. Hausner, and F. Sistare Novel biomarkers of acute kidney toxicity Clin Pharmacol Ther 86 2009 490 496